Method for inactivating viruses with slightly acidic arginine
AssigneeAjinomoto Co., Inc.
InventorsHajime Koyama, Tsutomu Arakawa, Daisuke Ejima
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for conveniently producing a protein formulation in which viruses are inactivated, without impairing the quality of the obtained protein formulation, characterized by including the step of exposing the protein formulation contaminated with the viruses to a 0.1-2M aqueous solution of arginine, an arginine derivative, or a mixture thereof, the aqueous solution being adjusted to pH 3.5 to 5. The present invention also provides a virus inactivation method characterized by including the step of contacting a virus-containing object with a 0.1-2M aqueous solution of arginine, an arginine derivative, or a mixture thereof, the aqueous solution being adjusted to pH 3.5 to 5.
Claims9
A method for producing a protein formulation in which lipid-enveloped viruses are inactivated, comprising:
- A) preparing an aqueous solution containing 0.1 to 2 M of arginine, an arginine derivative, or a mixture thereof, and
- B) exposing a protein formulation contaminated with one or more lipid-enveloped viruses to an amount of the aqueous solution sufficient to inactivate the lipid-enveloped viruses, wherein the pH of the resultant solution is in the range of between 4 and 5.
A method for inactivating lipid-enveloped viruses present in a protein formulation comprising:
- A) preparing an aqueous solution comprising 0.1 to 2 M of arginine, an arginine derivative, or a mixture thereof, and
- B) exposing a protein formulation contaminated with one or more lipid-enveloped viruses to an amount of the aqueous solution sufficient to inactivate the lipid-enveloped viruses, wherein the pH of the resultant solution is in the range of between 4 and 5.
Dependencies are inferred from the claim text.